Assoc. Prof. Pratap Singhasivanon Faculty of Tropical Medicine, Mahidol University Interactions The definitions • a situation where the risk or rate of disease in the presence of 2 or more risk factors differs from the rate expected to result from their individual effects • rate can be greater than expected - positive interaction or synergism • rate can be less than expected - negative interaction or antagonism • an interaction (or effect modification) is formed when a third variable modifies the relationship between an exposure and outcome Interaction When the incidence rate of disease in the presence of two or more risk factors differs from the incidence rate expected to result from their individual effects Interaction The effect can be greater than what we would expect (positive interaction) or less than we would expect (negative interaction) Interaction (Effect Modification) • Represents the phenomenon where the risk associated with the presence of two risk factors exceeds the risk we expect from the combination of the component risk X R1 Y R2 X and Y > R1 and R2 Interaction (Miettinen 1974) SAMPLE BASED (Statistical Interaction) POPULATION BASED (Effect Modification) (Biological Interaction) Statistical Interaction • Model Dependent • Depends on deviation from statistical model (not biologic) Additive Model Multiplicative Model Y Absent Present Absent R00 R01 Present R10 R11 X R10 Pr D X Y R 01 Pr D X Y R11 Pr D X Y R10 Pr D X Y RR11 = R11 / R00 RR01 = R01 / R00 RR10 = R10 / R00 Probability of disease in the presence of factors X and Y Probability of disease in the presence of factors X only Probability of disease in the presence of factors Y only Probability of disease in the absence of both X and Y Background RISK Additive Model 1. In term of excess over “ONE” ( RR11 1) ( RR101) ( RR011) Stage of “No interaction” on additive scale 2. HOGANS T R11 R10 R 01 R 00 0 Multiplicative Model RR11 RR10 RR01 Stage of “No interaction” on Multiplicative model Example : asbestos + smoke - + 50 10 - 5 1 Additive Model : (50-1) (10-1) + (5-1) Presence of “Interaction” on Additive model ID/1000 PY RR11 = 50/1 (smoking + asbestos) RR10 = 10/1 (smoking alone) RR10 = 5/1 (asbestos alone) Multiplicative Model : (50) = (10) * (5) Presence of “Interaction” on Multiplicative model Example : D D XY X Y X Y XY 40 20 20 10 60 80 80 90 100 100 100 100 = .4 RR11 = .4/.1 =4 R10 = R01 = 20/100 = .2 RR10 = .2/.1 =2 R00 = 10/100 RR01 = .2/.1 =2 R11 = 40/100 = .1 Multiplicative Model : RR11 = RR10 * RR01 4 = 2 * 2 No interaction on Multiplicative Model Additive Model : (RR11-1) (RR10-1)+(RR01-1) 3 1 + 1 T = R11-R10-R01+R00 = 0 = .40 - .20 - .20 + .10 = .10 There is evidence of interaction on Additive Model NOTES : 1. Neither model is right or wrong. They are simply devices for modeling data and may be more or less suitable for a particular application. 2. Most statistical techniques are based on multiplicative model. The presence or absence of interaction pertains to whether or not a particular effect measure (RR, OR) varies in value over categories or strata based on level of some factor(s). Equivalent to an assessment regarding interaction based on multiplicative model Which of the 2 models we should use : 1. For addressing public health concerns regarding disease frequency reduction, deviation from additivity appears to be most relevant 2. Contribution to the understanding of disease etiology multiplicative model Blood Pressure (Y) smokers Additive Model (No interaction) Non-smokers Only change in intercepts no change in slope irrespective of the value of Xi which is being held constant Age (X) Height (Y) Urban Interactive Model Rural Age (X) There is change in both intercepts and slope as the level of Xi which is held constant and varied χ TOTAL Wg ln(OR) 67.404 2 2 χ 2ASSO. ( Wg )θ̂ 2 (49.290)(1.0898) 2 58.54 θ̂ 2 Wg ln(OR) Wg χ HOMO. 67.404 58.54 8.86 2 53.717 1.0898 49.290 P < 0.005 Conclude that the non uniformity of the observed OR’s is unlikely to have occurred by chance; thus there is some evidence of interaction. males females VAC VAC VAC VAC D 10 14 D 22 12 D 191 15 D 155 17 201 29 177 29 P̂ 0.05 (P1) .483 (P2 ) .124 (P1 ) .414 (P2 ) RD .483-0.05 = .433 .144-.124 = .290 Males Females 0.433 0.290 (p1q1 n1 p1q 2 n 2 ) 0.08847 0.08979 3. Wg (1 Var(R̂D g ) 113.03 111.37 224.4 4. Wg (R̂D g ) 48.94 32.30 81.24 2 5. Wg (RD g ) 21.19 9.37 30.56 1. R̂D 2. Var( R̂D g ) 2 χ TOTAL 30.56 χ 2ASS 224.4(.362 ) 2 Total (θ̂)R̂D 81.24 224.4 .362 29.41 χ 2HOM O 30.56 29.41 1.15 Relative risk of oral cancer according to presence or absence or two exposures : smoking and alcohol consumption smoking No Yes No 1.00 1.53 Yes 1.23 5.71 alcohol Relative risk of liver cancer for persons exposed to Aflatoxin and/or Chronic Hepatitis B infection : An example of interaction Aflatoxin Negative Negative Positive 1.00 3.4 7.3 59.4 HBs Ag Positive Deaths from lung cancer (per 100,000) among individuals with and without exposure to cigarette smoking and asbestos Cigarette smoking No Yes Asbestos Exposure No Yes 11.3 58.4 122.6 601.6 Age-Adjusted Odds Ratios Estimated from Logistic Models with and without an Interaction between SMOKING and ORAL CONTRACEPTIVE USE No interaction Model Interaction Model OC Use OC use Cig/day No Yes No Yes None 1.0 3.3 (2.0, 5.5) 1.0 3.6 (1.2, 11.1) 1 - 24 3.1 (2.0, 4.6) 10.1 (5.2, 19.5) 3.3 (2.2, 5.1) 3.7 (1.04, 13.0) 25 8.5 (5.6, 12.8) 27.8 (14.4, 53.5) 8.0 (5.2, 12.4) 40.4 (19.4, 84.1) Conceptual Framework of the definition of interaction based on comparing expected and observed joint effects A. When there is no interaction, the joint effect of risk factors A and Z equals the sum of their independent effects : Z A A+Z Expected Observed Conceptual Framework of the definition of interaction based on comparing expected and observed joint effects B. When there is positive interaction (synergism). The observed joint effect of risk factors A and Z is greater than that expected on the basis of summing the independent effects of A and Z : Z A A+Z Expected Observed Excess due to positive interaction Conceptual Framework of the definition of interaction based on comparing expected and observed joint effects C. When there is negative interaction (antagonism), the observed joint effect of risk factors A and Z is smaller than that expected on the basis of summing the independent effects of A and Z : Z A A+Z * Expected Observed * “Deficit” due to negative interaction Schematic representation of the meaning of the formula, Expected ORA+Z+=Observed ORA+Z-+Observed ORA-Z+-1.0. (5) OR = 7.0 (4) OR = 4.0 (3) OR = 3.0 (2) OR = 2.0 (1) OR = 1.0 BL Baseline I A A A Z Z Z BL BL BL BL Baseline + excess due to A Baseline + excess due to Z Expected Joint OR based on adding absolute independent excesses due to A and Z* Observed joint OR> Expected OR. Excess due to I (Interaction) is not explainable on the basis of excess due to A and Z * Note that when the independent relative odds for A and Z are added, the baseline is added twice; thus, it is necessary to subtract 1.0 from the joint expected OR: that is, Expected ORA+Z+=(Excess due to A + baseline) + (Excess due to Z + baseline) – baseline = ORA+Z- + ORA-Z+ - 1.0. Factor B _ + Factor A _ + 3.0 9.0 15.0 Incidence Rates _ Factor B + _Factor A+ 3.0 9.0 15.0 21.0 Attributable Rates _ Factor B + Incidence Rates _ Factor B + _Factor A+ 3.0 9.0 15.0 21.0 _Factor A+ 0 6 12 Attributable Rates _ Factor B + _Factor A+ 0 6 12 18 Evans County Study Prospective cohort study of CVD and Cerebro vascular disease Logistic regression analysis of 10-year mortality among the members of this cohort (1904) 9 variables were considered for inclusion of the model Example of Logistic Regression Analysis of a prospective cohort study adapted from Evans County Study 1960-72 Variable coefficient Standard error of coefficient P value 40-69 years 0.08652 0.01153 < 0.001 Gender 0 = male ; 1 = female 1.49976 0.96723 0.121 Age X Gender Males : 0 ; Females : 40-69 -0.04296 0.01699 0.011 Race 0 = white ; 1 = black 1.59382 0.96355 0.098 SBP 88-310 mmHg 0.01943 0.00208 < 0.001 Diabetes 0 = no or suspect ; 1 = yes 1.12325 0.26134 < 0.001 Cigarette Smoking 0 = never smoke ; 1 = present or past smoker 0.31739 0.15682 0.043 Cholesterol 94-546 mg/100 ml 0.00311 0.00152 0.041 Quelet index X 100 2.107 – 8.761 -1.06415 0.43158 0.014 Variable Variable range Age SBP = systolic blood pressure Quelet index = weight in pounds divided by the square of height in inches Use of Logistic Regression Coefficient for calculation of the probability of dying over a ten-year period for a hypothetical individual Coefficient (log Odds for 1 unit) Value for hypothetical individual Product Age 0.08652 50 4.32600 Gender 1.49976 0 0.00000 Age X Gender -0.04296 0 0.00000 Race 1.59382 1 1.59382 SBP 0.01943 180 3.49740 Diabetes 1.12325 1 1.12325 Cigarette Smoking 0.31739 1 0.31739 Cholesterol 0.00311 350 1.08850 Quelet index X 100 -1.06415 3.2653 -3.47477 Variable Intercept -6.37626 Maximum Likelyhood estimates of logistic parameters (seven risk factors of coronary heart disease) Variable Parameter Estimate ( ˆi ) Standard Error ˆi of X0 interce0pt 0 -13.2573 X1 age (yr) 1 .1216 .0473 X2 cholesterol (mg/dl) 2 .0070 .0025 X3 systolic BP (mm Hg) 3 .0068 .0060 X4 relative Weight 4 .0257 .0091 X5 hemoglobin (g%) 5 -.0010 .0098 X6 cigarettes 6 .4223 .1031 X7 ECG Abnormality 7 .7206 .4009 X4 = relative weight (100 x actual weight / median for sex-height group) X6 = cigarettes per day (coded 0=never, 1=less than one pack, 2= one pack, 3= more than one pack) X7 = ECG (coded 0=normal, 1=abnormal) Prevalence of Down syndrome at Maternal Age 9 8 7 6 5 4 3 2 1 0 <20 20-24 25-29 30-34 Maternal Age 35-39 40+ Prevalence of Down syndrome at birth by birth order 1.8 1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 0 1 2 3 Birth Order 4 5+ Hypothetical Examples of Unadjusted and Adjusted Relative Risks According to Type of confounding (Positive or Negative) Example No. Type of Confounding Unadjusted Relative Risk Adjusted Relative Risk 1 Positive 3.5 1.0 2 Positive 3.5 2.1 3 Positive 0.3 0.7 4 Negative 1.0 3.2 5 Negative 1.5 3.2 6 Negative 0.8 0.2 7 Qualitative 2.0 0.7 8 Qualitative 0.6 1.8